Transdermal formulation comprising an opioid analgesic and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/70 (2006.01) A61K 31/485 (2006.01)

Patent

CA 2534338

The invention concerns a formulation comprising an apioid analgesic from the phenanthrene group or a pharmaceutically acceptable salt thereof as active ingredient and an aloe composition as transdermal penetration agent.

La présente invention concerne une formulation comprenant un analgésique opioïde provenant d'un groupe de phénanthrène ou un sel de celui-ci, acceptable d'un point de vue pharmaceutique, en tant que principe actif, et une composition d'aloès en tant qu'agent de pénétration transdermique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Transdermal formulation comprising an opioid analgesic and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transdermal formulation comprising an opioid analgesic and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal formulation comprising an opioid analgesic and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1823731

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.